Time for SL to become pharma sufficient

ToL Exclusive

With a vision to build an owner brand and a dream to make Sri Lanka self-sufficient in pharma, Sanjaya Jayaratne, the Chairman / CEO Navesta Pharmaceuticals embarked on establishing the first plant in 2017 for dry powder injectables. Their state-of-the-art plant caters to Sri Lanka’s total IV requirement in its production category, having started exports to the African region. The need in the market for capsules, syrups, and tablets in the antibiotic category made Navesta Pharmaceuticals set up the second plant. Their state-of-the-art plant caters for Sri Lanka’s total IV requirement in its production category, and will make its brand presence in many other nations.